Biontech Hühnerhaufen und nervöse Kommentare Forum: Community User: Werndl

Thekla du musst das nicht erwähnen, dass der link von mir ist! Dann sparst du dir einen Arbeitsschritt! Ich werde es aber weiterhin im Hauptforum posten, auch wegen der "Anderen" :)

https://www.africa.com/how-the-fastest-vaccine-development-in-history-is-being-gridlocked-by-socioeconomic-inequalities/ Prio2

LaJo danke

Pfizer chief scientist rejects criticism on COVID-19 booster push; defends jab’s potency Sep. 08, 2021 7:39 AM ETPfizer Inc. (PFE), BNTXAstraZeneca PLC (AZN)Moderna, Inc. (MRNA)Johnson & Johnson (JNJ)By: Dulan Lokuwithana, SA News Editor Wachiwit/iStock via Getty Images Philip Dormitzer, the chief scientific officer of Pfizer (NYSE:PFE), shrugs off criticism that the company was too aggressively promoting the rollout of COVID-19 booster shots. Amid concerns over its declining efficacy, he also defended the potency of the vaccine, the U.S. pharma giant co-developed with its German partner BioNTech (NASDAQ:BNTX). “Our job is to create the tool that’s going to be needed for the problem that’s coming,” Dormitzer told the Financial Times. “If we waited until there was just widespread breakthroughs of severe disease to advance a solution, we would be way too late.” The comments of Pfizer’s top scientist come as U.S. plans to roll out COVID-19 booster shots for all Americans in a few days, beginning with the messenger-RNA-based shot developed by Pfizer (PFE) and BioNTech (BNTX). “Being very proactive and making sure that the solution is in place ahead of a crisis is important — I think it’s the right thing to do,” he added, noting that the responsibility for “the decision to deploy the solutions” lies with policymakers, not with Pfizer (PFE). Meanwhile, arguing that booster shots might not be required for everyone, Pascal Soriot, CEO of AstraZeneca (NASDAQ:AZN) urged the U.K. government to wait until data brings more clarity. It was important to understand how long the efficacy of two doses last and protect the U.K. health service from a potential “unnecessary burden,” Financial Times reported, quoting the comments of Soriot published in The Telegraph. On potency of Pfizer/BioNTech COVID-19 shot amid evidence that the rival jab from Moderna (NASDAQ:MRNA) elicited a stronger immune response, Dormitzer said: “We used the minimum dose level that gave us an immune response in older adults that was greater than the immune response that we saw after natural infection.” “We made experience-based and evidence-based careful decisions about where we were going to go to balance strong immune response versus reactogenicity,” he added, referring to the term used by the scientific community to identify side effects in clinical trials. A recent study published in the Journal of the American Medical Association indicated that Moderna’s (MRNA) shot led to more than twice the level of antibodies as that generated from Pfizer (PFE)/BioNTech (BNTX) COVID-19 vaccine. ..

von Vienna73 Israel mögliche 4.Impfdosis https://www.msn.com/de-at/nachrichten/ausland/israel-bereitet-sich-auf-m%C3%B6gliche-vierte-impfdosis-vor/ar-AAOdpKG?ocid=entnewsntp

von DE56 Keine Besorgnis wegen geringerer Antikörper bei BioNTech https://www.nasdaq.com/articles/moderna-beats-pfizer-by-this-1-measure.-heres-why-pfizer-investors-shouldnt-worry.-2021-09

von Mausheister Wenn wir auf STIKO warten haben wir die ersten Tote https://www.n-tv.de/politik/Wenn-wir-auf-STIKO-warten-haben-wir-die-ersten-Toten-article22791550.html

https://www.4investors.de/nachrichten/mobile/boerse.php?sektion=stock&ID=155878

von Hotzenplotz5 BioNTech Aktie nimmt Fahrt auf..... Boden gefunden

von TraderausBerlin BioNTech für 5-11 jährige Spätherbst bis früher Winter https://texasnewstoday.com/dr-scott-gottlieb-pfizers-director-talks-about-the-covid-vaccine-for-children-ages-5-11/436784/

Von Hotzenplotz5 Coronavirus wird nicht verschwinden https://seekingalpha.com/news/3737810-who-says-coronavirus-is-here-to-stay-elimination-unlikely

Moin1234 Danke, ist ein kleines Nebenprodukt, wenn wir nicht vor den Trollen hierher flüchten müssen, ist Platz genug für Links

Danke Thekla und Werndl, das ist ne gute Sache von Euch, wenn mann nicht die Zeit hat im hauptforum alles nach zu lesen, hier kurz und bündig das wichtigste findet. 👍

von TraderausBerlin BioNTech für unter 12jährige https://www.pharmazeutische-zeitung.de/biontech-impfstoff-fuer-kinder-unter-zwoelf-noch-in-diesem-jahr-127871/

@Werndl das ist vielleicht für den schnellen Überblick hilfreich und dann ist dieses Forum nicht nutzlos, wenn wir keine Trolle haben

Guten Morgen. Danke thekla, dass du hier alles so schön gefiltert einstellst, was interessant ist.